CompletedNCT06175559
Official study titleEmbedded Narrative in Interactive Game Design for Improving Medication Adherence of Schizophrenia:Exploratory Research
This study has finished and is no longer accepting participants.
In ShanghaiSchizophreniaInterventional studyAges 18–60
- Countries
- China
- Sponsor
- Zhu Dian
CompletedNCT05345977
Official study titleeMotiph: Smart and Innovative E-mental Health Solution to Manage Patients With Schizophrenia
This study has finished and is no longer accepting participants.
In BarcelonaSchizophreniaDevice studyAges 18–55
- Countries
- Spain
- Sponsor
- Grupo Pulso
Active Not RecruitingNCT02926859
Official study titleEnhancing Recovery in Early Schizophrenia - a Multi-center, Two-arm, Double-blind, Randomized Phase II Trial Investigating Cannabidiol vs. Placebo as an add-on to an Individualized Antipsychotic Treatment
This study is no longer accepting new participants.
Multiple locations, including MannheimSchizophreniaMedication studyAges 18–65
- Countries
- Germany
- Sponsor
- Central Institute of Mental Health, Mannheim
TerminatedNCT02512367
Official study titleEfficacy of a Dental Health Promotion Program in Patients With Schizophrenia
This study ended early.
Multiple locations, including BesançonSchizophreniaPlacebo comparisonAges 18+
- Countries
- France
- Sponsor
- Centre Hospitalier Universitaire Dijon
CompletedNCT05449977
Official study titleEvaluation of Physical Activity, Physical Fitness, and Quality of Life in Patients With Schizophrenia Utilized From Community Mental Health Center Services
This study has finished and is no longer accepting participants.
In IstanbulSchizophreniaObservational studyAges 18–95
- Countries
- Türkiye
- Sponsor
- Yeditepe University
CompletedNCT00236353
Official study titleAn Open-label Study of the Efficacy and Safety of RISPERDAL Long-acting Microspheres (RISPERDAL CONSTA) Administered Once Monthly in Adults With Schizophrenia or Schizoaffective Disorder
This study has finished and is no longer accepting participants.
Location not clearly listedSchizophreniaMedication studyAges 18–65
- Countries
- Sponsor
- Janssen, LP
CompletedNCT05257720
Official study titleEvaluation of the Role of Neurodegeneration in Treatment Resistant Schizophrenia With GFAP and S100B
This study has finished and is no longer accepting participants.
In IstanbulSchizophreniaObservational studyAges 18–65
- Countries
- Türkiye
- Sponsor
- Istanbul Saglik Bilimleri University
CompletedNCT00236548
Official study titleAn Open-label Evaluation of the Utility of the RISPERDAL CONSTA Treatment Guidebook During Transition of Adult Patients With Schizophrenia or Schizoaffective Disorder to RISPERDAL CONSTA (Risperidone) Treatment Over Three Months in the Community Mental Health Center (CMHC) Setting
This study has finished and is no longer accepting participants.
Location not clearly listedSchizophreniaMedication studyAges 18–65
- Countries
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
WithdrawnNCT00916201
What is this study about?Researchers are comparing intranasal Insulin, Cannabidiol CR and URB597 to find out how the approaches affect depression symptoms in healthy volunteers.
This study was withdrawn before enrollment.
In MannheimSchizophreniaMedication studyAges 18–65
- Countries
- Germany
- Sponsor
- Central Institute of Mental Health, Mannheim
CompletedNCT04602741
This study has finished and is no longer accepting participants.
In TorontoSchizophreniaBehavioural studyAges 18+
- Countries
- Canada
- Sponsor
- Centre for Addiction and Mental Health (Hospital / academic medical center)
CompletedNCT05438160
Official study titleA Multi-center, Exploratory, Single-Arm, 7-week Study to Evaluate the Feasibility and Acceptability of the Medication Tracking and Educational Components of a Clinical Learning Version of CT-155 in People With Schizophrenia
This study has finished and is no longer accepting participants.
Multiple locations, including AnaheimSchizophreniaDevice studyAges 18–64
- Countries
- United States
- Sponsor
- Click Therapeutics, Inc.
CompletedNCT04941677
Official study titleExploration of the Relationships Between Vocational Performances Ans Sensorimotor Factors of Hands in Schizophrenia
This study has finished and is no longer accepting participants.
In TainanSchizophreniaObservational studyAges 20–65
- Countries
- Taiwan
- Sponsor
- National Cheng-Kung University Hospital